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Introduction 
Uterine leiomyoma are benign smooth muscle tumors within the uterus (Lewis, 
2004). Their etiology is unknown and they may cause a number of symptoms including 
urinary frequency, constipation, dyspareunia, and menorrhagia (Pron et al., (2003). 
Complications such as miscarriage, dysfunctional labor, Breech births, Caesarean 
sections and other problems of pregnancy, labor and birth are increased in women with 
leiomyoma as well (Coronado, Marshall, & Schwartz, 2000). Furthermore, the majority 
of all hysterectomies, which is the second most performed surgery in the United States, 
are received by women with uterine leiomyomas (Velebil, Wingo, Xia, Wilcox, & 
Peterson, 1995). Although uterine leiomyomas are one of the most common 
gynecological conditions, the condition does not receive much attention from the media 
or researchers. 
Symptom severity and quality of life of women with leiomyomas have been 
investigated individually and along with other gynecological disorders. Many of these 
studies focused on the participants’ pain and menorrhagia. Few studies have evaluated 
the severity of symptoms such as bloating, constipation, and urinary frequency, which are 
unique to women with uterine leiomyomas because they are related to the bulk or 
placement of the leiomyomas. Thus, the purpose of this study was to evaluate the 
symptom severity and health-related quality of life of women with uterine leiomyoma 
using a tool that evaluates common symptoms of the condition. The possible correlation 
between symptom severity and health-related quality of life was also assessed.  
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Review of Literature 
Prevalence of Leiomyoma in the Population 
Results from a study by Velebil et al. (1995), which analyzed data from the 
National Hospital Discharge Survey from 1988 to 1990, suggest that the average annual 
rate of uterine leiomyomas was 30.4 per 10,000 women between the ages and 15 and 40, 
making uterine leiomyomas one of the most frequently diagnosed gynecological 
disorders. Eighty-three percent of these women had a hysterectomy. 
Racial Differences in Rate of Diagnosis  
Findings suggest variation in the rate of uterine leiomyoma diagnosis among 
demographic groups. Marshall et al. (1997) examined the differences in the incidence of 
uterine leiomyoma among women of various races and age groups. As part of the Nurses’ 
Health Study II cohort, 95,061 premenopausal nurses, age 25-44 with uteri, and no 
current diagnosis of uterine leiomyomas, were followed to determine the incidence over 
four years. The incidence rate per 1000 women years among black women (37.9) was 
significantly greater than rates among white (12.5), Hispanic (14.5) and Asian women 
(10.4).  
Data from the National Hospital Discharge Survey also showed differences 
among racial groups and the rate of uterine leiomyoma diagnosis. More women of races 
other than white were discharged with a primary diagnosis of uterine leiomyoma (53.2 
per 10,000) compared to white women (24.4 per 10,000). The rate of diagnosis of uterine 
leiomyomas for women of races other than white was significantly higher than white 
women in the 30-34, 35-39, and 40-44 age groups. The race or ethnicity was not specified 
in the women of color group (Velebil et al., 1995).  
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Racial Differences in Age at Diagnosis  
There appears to be strong evidence that there is a difference in the age at 
diagnosis between racial groups. Kjerulff et al. (1996) examined the differences in 
incidence of uterine leiomyomas, symptom severity, and age at diagnosis between black 
and white women hysterectomy patients. The longitudinal study included 301 black and 
281 white women whose presurgery diagnosis of uterine leiomyomas was confirmed by 
surgery. The average age at diagnosis of uterine leiomyomas was 41.6 years for white 
women and 37.5 years for black women. The 30 to 39 age group included 48% black 
women and 32% white women. This finding is important because in a previous analysis 
by Kjerulff, Guzinski, Langenberg, Stolley, Moye, and Kazandjian (1993), black women 
had higher annual rates for hysterectomies before the age of 40 compared to white 
women. This may be because black women are more likely to be diagnosed at a younger 
age. This finding is also supported by Marshall et al. (1997) who found that black women 
were more frequently diagnosed at a younger age than the white, Hispanic and Asian 
groups. It is important to note that the incidence of uterine leiomyomas increased with 
age within all groups in this study.  
Racial Differences in Symptom Severity 
 Findings in Kjerulff’s study (1996) also illustrated a great difference in symptom 
severity between black and white women. A significantly larger percent of black women 
were more likely to report having very severe or severe pain, constipation and more 
stomachaches. Anemia, which was defined as a presurgical hematocrit of less than 35%, 
was found in 56% of black women compared to 38% of white women did. 
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Pron et al. (2003) also examined the variation of symptoms reported among races 
in a study including 555 women with uterine leiomyomas undergoing uterine artery 
embolization. Fibroid related symptoms were categorized into four groups including 
pelvic pain, pelvic pain with bleeding, bleeding only, and bulk related effects without 
pain or bleeding. White women with uterine leiomyomas were significantly more likely 
to report having bulk related symptoms, whereas black women were more likely to report 
having a combination of pain and bleeding. In addition, black women reported a 
significantly longer mean duration of years in which they experienced symptoms than 
white women. 
Racial Differences in Hysterectomy Rates 
Kjerulff et al. (1993) explored the racial differences in hysterectomy rates. 
Discharge summaries from 53,159 women with hysterectomies performed in Maryland 
between 1986 and 1991 were used for the study. The data set included 70% white 
women, 26% black women, and 3% other races including Hispanic, Asian and Eskimo, 
but only white and black women were included in the analysis. Primary diagnoses, type 
of hysterectomy (abdominal, vaginal, or subtotal) patient age, source of payment and 
complications of surgical and medical care were analyzed. 
Black women in Maryland received hysterectomies an average of four years 
younger than white women (46.1 vs. 42.0). The average annual rate of hysterectomy was 
higher for black women in all age groups to the age of 49. However, white women had 
higher rates after the age of 50. Twice as many black women with a primary diagnosis of 
uterine leiomyoma had hysterectomies than did white women (65.4% vs. 28.5%) 
(Kjerulff et al., 1993). Black women were also more likely to have abdominal 
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hysterectomies than white women. This finding is important because having an 
abdominal hysterectomy was significantly correlated with complications after the 
procedure. Overall, 19.7% of black women had one or more complications compared to 
10% of white women. The average length of stay was significantly longer for black 
women than white women as. The increased symptom severity of African-American 
women may explain why they are significantly more likely to receive hysterectomies, in 
general, and at a younger age. 
Effect of symptoms on Psychological Well-being 
 Rannestad, Eikeland, Helland, and Qvarnstrom (2000) investigated the impact 
pain has on quality of life and psychological well-being among women with 
gynecological disorders. The study consisted of 111 women with benign gynecological 
disorders, including uterine leiomyomas, undergoing hysterectomies. The control group 
consisted of 173 women of similar age and intact uteri. The Quality of Life Index (QLI) 
and the McGill Pain questionnaire were used. The psychological/spiritual domain of the 
QLI was used to determine psychological well-being. Pain had a negative effect on 
quality of life for both groups, however, the mean scores for participants with 
gynecological disorders were lower on the overall QLI compared to the control group, 
regardless of the frequency of pain (Rannestad et al., 2000).  
The participants with gynecological disorders also had significantly lower means 
for the health functioning subscale items of the QLI than the control group. In contrast, 
there was no significant difference in the psychological/spiritual subscale score indicating 
that women with gynecological disorders do not differ psychologically from women 
without these disorders (Rannestad et al., 2000).  
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Alternatively, findings from a study by Salter (1985) suggest that there is an 
association between specific symptoms and psychological well-being of women who 
suffer from gynecological disorders. The study included 102 women who sought 
treatment for various gynecological disorders. The Anxiety sub-scale from the Kellner-
Sheffield self-rating scale of distress measured anxiety while depression was measured 
with the Zung Depression Scale. Factors such as flooding, clotting, and discomfort during 
menstrual periods, which were part of the bleeding component, had a positive correlation 
with depression. Painful periods were positively correlated with the anxiety. This finding 
is important because women with uterine leiomyoma often suffer from pain and heavy 
bleeding, so they have a definite risk for developing depression and anxiety. 
Symptom Severity of Women with Leiomyoma 
 
Uterine leiomyomas can produce a number of unpleasant symptoms. Pron et al. 
(2003) evaluated these symptoms, including their severity, in women with uterine 
leiomyomas. The most frequently reported symptom was heavy bleeding (80%). Anemia 
from chronic blood loss was a secondary problem for many of these women. Pelvic pain 
was the second most reported symptom (75%). Sixty-three percent of women reported 
having a combination of pain and bleeding. Bulk related symptoms caused urinary 
frequency, back pain, and dyspareunia. Women also reported a limited ability to exercise, 
but it was not stated if this was related to fatigue, pain, heavy bleeding, or body image 
disturbance related to the appearance of being pregnant. Forty percent of women reported 
taking time off work, usually during the menstrual period, because of their symptoms. 
This finding suggests that many women suffering from leiomyomas may experience an 
additional financial burden due to missing work as well.  Overall, 58% of the participants 
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reported a fibroid (leiomyoma) impact scale score of 7 on a scale of 0 to 10. This 
indicates that their symptoms truly interfere with their daily or usual activities (Pron et 
al., 2003). 
The Effects of Symptom Severity on Quality of Life 
 
There appears to be strong evidence that women with leiomyomas have 
symptoms that negatively affect many aspects of their quality of life. Rowe, Kanouse, 
Mittman, and Bernstein (1999) conducted a study measuring the association between 
quality of life and symptoms of common gynecological conditions. The retrospective 
study was conducted for three years and included 482 women (61% with uterine 
leiomyomata) who had hysterectomies for benign conditions. The women were placed in 
four groups, (bleeding, pain, pelvic discomfort, and asymptomatic) based on the principal 
characteristic of their symptoms. Women with bleeding uterine leiomyomas were placed 
in the bleeding group. Women with uterine leiomyomas without bleeding were placed in 
the pelvic discomfort group. It is important to note that the primary pain group did not 
specifically include women with uterine leiomyomas; however, women with uterine 
leiomyomas frequently experience dysmenorrhea. The groups were then compared to 
examine differences in six quality of life scales: role, sexual mood impairment, 
impairment due to bleeding, change in symptom severity, and general health perception.  
The women in the pain group had significantly higher role, sexual and mood 
impairment and symptom severity than all other groups. The bleeding group had a 
significantly higher impairment due to bleeding than the three other groups. Overall, the 
pain group had a significantly higher mean general health perception score (74.4) than the 
bleeding group (60.7), the pelvic discomfort group (44.1) and the asymptomatic group 
                                                                Symptom severity and quality of life  9
(49.4). Higher scores indicate more impairment in all quality of life scales (Rowe et al., 
1999). 
To illustrate the extent to which gynecological conditions negatively affected 
quality of life, the mean of the emotional well being scores for each group in the study 
was compared to the mean emotional well-being score of women with other medical and 
psychiatric conditions. The mood impairment scale, which measures depression and 
anxiety, was used to analyze the emotional well being of different populations. Each of 
the four groups scored significantly worse on the mood impairment scale than women 
with hypertension, diabetes, heart disease, and arthritis (Rowe et al., 1999).  
Carlson, Miller, and Fowler (1994) analyzed the quality of life and symptom 
severity of women having hysterectomy. The Maine Women's Health Study was a 
prospective study that analyzed the outcomes of hysterectomy for nonmalignant 
gynecological disorders. The participants were placed in four groups (leiomyoma, 
abnormal bleeding, chronic pain or other) depending on their principal diagnosis. The 
symptom severity of the 418 women was analyzed. The reported symptom severity for 
women diagnosed with uterine leiomyomas, (about 40% of the participants) before 
surgery included 43% experiencing bleeding for more than eight days a month, 45% with 
pelvic pain more than eight days a month, 74% reporting some or a lot of discomfort. 
Forty-nine percent of the women with leiomyoma had 12 week pregnancy uterus size. 
Quality of life was measured preoperatively, and at six and twelve months 
postoperatively, using the Mental Health index, the General Health index and the Activity 
index. Overall, symptom severity in all groups was significantly improved at six and 
twelve months after hysterectomy. Additionally, there was a significant improvement in 
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quality of life scores on all indices for all four groups at six and twelve months after 
surgery. 
Summary 
Most studies have analyzed symptom severity and quality of life of gynecological 
disorders in general. As a result, many of the symptoms that are unique to uterine 
leiomyoma such as bloating, constipation, urinary frequency and bulk weight gain have 
not been assessed. There is limited information concerning symptom severity and quality 
of life of women with uterine leiomyomas. Thus, this study was conducted to determine 
symptom severity and health-related quality of life of women with uterine leiomyomas 
using the Uterine Fibroid Symptom and Health Related Quality of Life (UFS-QOL) tool 
which was developed by Spies et al. (2002). 
Methods 
The researchers analyzed three research questions: (1) What is the symptom 
severity for women with uterine leiomyomas? (2) What is the health-related quality of 
life for women with uterine leiomyomas? (3) How does symptom severity affect the 
health-related quality of life for these women? The hypothesis was that women with the 
worst symptom severity would have the lowest quality of life. 
Human Subjects Concern 
The study was reviewed and approved by the Institutional Review Board. 
Participation in the study was completely voluntary.  An informed consent statement was 
included with the questionnaire. The participant’s right to self-determination was assured 
since the only questionnaires included in the data collection were returned questionnaires 
with signed informed consent forms. The purpose of this study, which was to analyze the 
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symptom severity, quality of life and possible correlation between the two, was explained 
to the possible participants when they contacted the researcher by email or phone to 
ensure full disclosure of the study. The participant had the right not to answer any 
question for any reason. Since some questions might generate emotional distress, the 
participants were encouraged to contact the researchers if this should happen. The 
informed consent sheet was separated from the completed questionnaire before any data 
were analyzed to ensure confidentiality. All completed questionnaires and informed 
consent forms were locked in a container in a secure office at the Ohio State University 
College of Nursing. 
Participants 
  The inclusion criteria were premenopausal women over the age of 18 diagnosed 
with uterine leiomyomas, with intact uteri who had a menstrual cycle in the last 3 
months. They had to be able to read and speak English.  
Instrument  
Symptom severity and health-related quality of life was measured using the 
Uterine Fibroid Symptom and Health-Related Quality of life questionnaire. Spies et al. 
(2002) developed the UFS-QOL using 110 women with leiomyomas and 29 normal 
women not diagnosed with uterine leiomyomas. Symptom severity is measured using 8 
items and health-related quality of life is measured using 29 items. There are 6 subscales 
for health-related quality of life: concern, activities, energy/mood, control, self-
consciousness, and sexual function.  
Symptom severity, health-related quality of life and each subscale score are 
transformed into a 0 to 100 point scale. For symptom severity, a score of 0 would 
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represent no symptom severity, while a score of 100 represents an extreme symptom 
severity. For health-related quality of life and each subscale, a score of 0 represents no 
quality of life while a score of 100 represents an optimal quality of life. Hence, a negative 
correlation would be expected between symptom severity and health-related quality of 
life. 
The UFS-QOL was found to have discriminant validity because women with 
symptomatic leiomyomas had significantly lower scores for health-related quality of life 
and significantly higher scores on the symptom severity items, which indicates a lower 
quality of life and more symptom severity than the non-leiomyoma group. The UFS-QOL 
was also able to discriminate between women with mild, moderate or severe symptoms of 
leiomyoma of symptomatic leiomyomas. Test-retest reliability was confirmed by high 
correlations found between the scores of 27 women on the original questionnaire to 
scores on the second completion of the same questionnaire (Spies et al., 2002).  
Symptom severity and health-related quality of life were also analyzed using 
single items. Participants rated their symptom severity and health-related quality of life 
on a 0 to 10 scale. For symptom severity a score of 0 would indicate no symptom 
severity, while a score of 10 would be extreme symptom severity. For health-related 
quality of life, a score of 0 would indicate poor health-related quality of life and a score 
of 10 would represent an optimal quality of life. A negative correlation would be 
expected for the single items as well. 
Procedure 
The researcher posted flyers in public places, such as grocery stores, libraries, 
and shopping malls. Some advertisements were placed in newspapers and websites. 
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Potential participants contacted the researcher by email or phone. The purpose of the 
study was explained at that time. If the individual agreed to participate then the 
researcher asked the participant the following questions: Are you at lest 18 years old? Do 
you still have a uterus? Have you had your period in the last 3 months? Has your 
physician or nurse practitioner diagnosed you with leiomyomas? If the participant met the 
criteria the researcher sent the informed consent sheet and the questionnaire to them, with 
a stamped envelope.  Participants completed all items and returned them by mail.  
Data Analysis 
Descriptive analysis of the demographic data and research questions 1 and 2 was 
performed. The correlation between symptom severity and quality of life was analyzed 
using Pearson’s r. The alpha level of significance was set at 0.05. The outcome of the 
hypothesis was tested using a directional (one-tailed) Pearson’s r test, with an alpha level 
of significance at 0.05. 
Results 
Participant Characteristics 
There were 46 women in the study. The average age of the women was 42 years 
(SD=7.6; range, 28-55 years). The majority of the women (N = 35; 76.1%) were white; 
15.2% were black and 8.7% were of other races.  
Most of the women had a Bachelor’s or Graduate degree (N = 28; 60.9%). Most 
women in the study were employed full time (N = 35; 76.1%). More than half of the 
women had been pregnant (60.9%).  As shown in Table 1, twenty-one participants had 
received treatment for their leiomyomas (47.8%), including myomectomy, birth control, 
progesterone, uterine artery embolisms, and acupuncture.  
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Symptom Severity and Health-Related Quality of Life  
The mean symptom severity score on the UFS-QOL was 59.3 (SD=19.9; range, 
12.5-100). The mean heath-related quality of life score for the UFS-QOL was 43.2 
(SD=21.0; range, 4.31-86.2). The symptom severity and health-related quality of life 
scores were significantly correlated [r = -0.68 (p<0.01)], thus supporting the hypothesis.  
Single items, rated 0 to 10, in addition to the UFS-QOL, also measured symptom 
severity and health-related quality of life. The mean score of the single item that 
measured symptom severity was 7.1 (SD=2.1). The mean score of the single item that 
measured health-related quality of life was 6.1 (SD=2.2). These were not significantly 
correlated (r = -0.14).  There was a significant correlation between the single item 
symptom severity score and the symptom severity score of the UFS-QOL (r = 0.68, 
p<0.01). However, the single item and UFS-QOL scores that measured health-related 
quality of life were not significantly related (r = 0.17).  
The researchers proceeded to examine the six subscales. The means of the six 
subscales, which ranged from 38.9 to 46.4, are listed in Table 2. There was a significant, 
negative correlation between symptom severity and each of the six subscales. (Table 3 
shows these results). 
Because the researchers were interested in the differences among women of color 
and white participants, symptom severity and the health-related quality of life on the 
UFS-QOL were analyzed for both groups. The mean symptom severity score on the UFS-
QOL for women of color was 57.4 (SD=23.9) and 60.0 (SD=18.9) for the white 
participants. The mean health-related quality of life score for women of color on the 
UFS-QOL was 38.1 (SD=25.6), while the mean score for white participants was 45.1 
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 This study evaluated the symptom severity and heath-related quality of life of 
women with uterine leiomyomas. The mean symptom severity scores on the UFS-QOL 
indicated that the participants had a moderate symptom severity. As a result, their mean 
health-related quality of life scores on the UFS-QOL were considerably reduced from 
what would be considered an average health-related quality of life. The correlations 
between these scores were negative and significant, thus supporting the hypothesis. These 
findings complement a study by Rannestad et al. (2000), which also found that the 
symptoms of women with various gynecological conditions have a negative impact on 
the quality of life. This study further supports the fact that women with gynecological 
conditions, including uterine leiomyomas have a considerably decreased quality of life.  
Findings from a previous study by Salter (1985), implied that symptoms such as 
excessive bleeding and pain, that are experienced with various gynecological conditions, 
increase the risk of anxiety and depression of women with gynecological conditions. The 
results of this study suggest that women with uterine leiomyomas, who may experience 
pain and bleeding as well as bulk symptoms, are specifically at a risk as well. In the 
present study the participants’ symptom severity was significantly correlated with all six 
domains. Thus, it can be construed that women with symptomatic leiomyomas are at risk 
for depression and anxiety because, according to the UFS-QOL, the more severe the 
participants’ symptoms were, the more likely the participants felt hopeless, self-conscious 
about their appearance, or were less productive at work. Additionally, the more severe the 
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symptoms were, the more likely that the participants would avoid physical activity and 
sexual relations, which may lead to a decrease in self-esteem and relationship problems.  
The symptom severity scores of the women of color indicated that they 
experienced less severe symptoms than white participants. However, the women of color 
health-related quality of life scores were lower on average, which suggests that they have 
a poorer quality of life than that of white participants. Still, there was no significant 
difference between the two groups for health-related quality of life or symptom severity. 
These findings are contradictory to those found by Kjerulff et al. (1996), which found 
that black women with leiomyomas had significantly worse symptom severity than white 
participants.  
Implications for Research 
In the present study, there were a limited number of African-American 
participants, so the researchers analyzed the differences in symptom severity and health-
related quality of life of all women of color, which included African-American, Hispanic 
and Asian women. The literature suggests that African-American women have greater 
symptom severity than white women and other ethnic minorities (Kjerulff et al. 1996; 
Pron et al., 2003). The fact that there were a limited number of African-American 
participants in the study may explain why these results were not significant. Future 
research should recruit larger populations of African-Americans and other ethnic 
minorities to analyze potential racial differences in results on the UFS-QOL between 
them and white participants.  
 This study included women who had intact uteri, so women who have had 
hysterectomies were not included. Women with the worst symptom severity and the 
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poorest quality of life are more likely to receive hysterectomies to bring an end to their 
symptoms and improve their quality of life (Carlson et al., 1994), yet it is important to 
note that 46% (n=21) of the women in the study had some type of treatment for their 
leiomyomas. Thus, in future studies, researchers may consider having participants 
complete the UFS-QOL before and after any treatment for their leiomyomas to evaluate 
the effectiveness of the treatment.  
Implications for Nursing 
By using the UFS-QOL, a tool that analyzes symptoms unique to uterine 
leiomyomas, the researchers found that women who have symptomatic leiomyomas are at 
risk for having a poor quality of life. More specifically, the participants’ symptom 
severity seemed to have the most impact on their activity levels. This finding along with 
those of Pron et al. (2003) implies that women with symptomatic uterine leiomyomas 
may not exercise, travel or do other activities as much as they would like. As a result, 
nurses should not only discuss management of physical symptoms with patients, but they 
should also be certain to assess the activity level of the client and implement 
interventions that will help the client to maintain an activity level that is desirable to the 
client. Furthermore, the results of this study suggest that the symptom severity of the 
participants had a damaging impact on their energy levels and self-consciousness. 
Engaging in physical activity is especially beneficial since it has been shown to improve  
mood, decrease fatigue and increase vigor (Lane & Lovejoy, 2001).  
Practitioners may also consider using the UFS-QOL as an additional assessment 
to help guide decisions about a patient’s plan of care. For instance, in this study, the 
participants’ symptom severity negatively affected all six subscales of the health-related 
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quality of life on the UFS-QOL. Problems relating to subscales like concern and self-
consciousness may be difficult for an individual to clearly express. Additionally, it is not 
likely that patients inform their practitioners about any emotional problems or a decrease 
in quality of life that they may be experiencing as a result of their leiomyoma symptoms. 
Subjective symptoms such as pain, discomfort and bloating are also difficult for a 
practitioner to assess. Therefore, practitioners may use this tool as a way to facilitate 
communication between the practitioner and patient in regards to physical and emotional 
concerns that affect the patient’s quality of life. 
Limitations  
One of the limitations of this study was the small sample size. A larger sample 
size may have helped identify a stronger relationship between symptom severity and 
heath-related quality of life.  
Another major limitation of the study was that the single scaled items were stated 
in a way that may have altered the anticipated results. The items were the last two on the 
demographics page, and the researchers believe that the participants did not take note as 
to how the questions were arranged.  In future studies, the items should be stated so the 
best and worst ratings are absolutely clear for symptom severity and health-related 
quality of life.  
In conclusion, women with symptomatic leiomyomas are at risk for developing a 
poor health-related quality of life. Thus, it is important that nurses are aware of the 
common problems that accompany symptomatic leiomyomas in order to help women 
manage their physical symptoms and minimize their psychosocial distress, thus 
maximizing their quality of life.  
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Table 1 
Treatment Types 
Treatment                                                         N = 21                     Percent  
Myomectomy                                                     6                                28.6 
Birth Control                                       3               14.3 
Uterine Artery Embolization                 3    14.3 
Complementary and Alternative Medicine    4    19.0                 
Multiple                                                             4                                 19.0 
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Table 2                
UFS-QOL Subscales 
                                Mean                Standard Deviation 
Concern                    41.2                             29.0 
Activity                    44.3                              23.6 
Energy/Mood           46.4                              26.2 
Control                     44.1                              24.7 
Self-Consciousness  38.9                              29.1 
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Table 3 
Correlations between Symptom Severity and HRQL and Six Subscales 
HRQL     Concern     Activity    Energy    Controls    Self-                             Sex                 
______________________________________________Consciousness__________ 
Symptom      
Severity       -0.68**     -.054**     -0.69**    -0.59**    -0.47**       -0.43*           0.36*        
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